Study Finds Syringe Models Differ Widely in Residual Technetium-99m Radiopharmaceutical Retention
A comparative laboratory study reveals that residual retention of technetium-99m tetrofosmin differs significantly across specific commercial three-part syringe models, demonstrating ...

















![Research report: Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [11C]AZ14193391](https://bioengineer.org/wp-content/uploads/2026/11/stackrss-featured-4179-350x250.png)


